RESUMEN
AIM: To evaluate prospectively the hemodynamic performance of «BioLAB Mono¼ stentless bioprosthesis implanted into aortic position. MATERIAL AND METHODS: Twenty seven patients (mean age 71 (67; 73); 17 women) with severe aortic stenosis underwent aortic valve replacement with «BioLAB Mono¼ stentless bioprosthesis from 2012 to 2014. The valves were implanted into supra-annular position using continuous polypropylene suture. RESULTS: In the early postoperative period 1 patient (3.7%) died for acute heart failure. The mean aortic cross-clamping time was 81 (75; 90) min. Echocardiographic peak pressure gradient were 18 (16; 23) mmHg (postoperative). There were no cases of valve dysfunction in early postoperative period. Level of thrombocytes recovered after 10 days postoperatively. CONCLUSION: «BioLAB Mono¼ aortic bioprosthesis implantation is easy and reproducible. The valve has excellent hemodynamic performance in early postoperative period.
Asunto(s)
Estenosis de la Válvula Aórtica/cirugía , Bioprótesis , Insuficiencia Cardíaca , Implantación de Prótesis de Válvulas Cardíacas , Prótesis Valvulares Cardíacas , Complicaciones Posoperatorias , Diseño de Prótesis/métodos , Anciano , Válvula Aórtica/cirugía , Estenosis de la Válvula Aórtica/diagnóstico , Estenosis de la Válvula Aórtica/fisiopatología , Ecocardiografía/métodos , Femenino , Insuficiencia Cardíaca/diagnóstico , Insuficiencia Cardíaca/etiología , Insuficiencia Cardíaca/fisiopatología , Insuficiencia Cardíaca/prevención & control , Implantación de Prótesis de Válvulas Cardíacas/efectos adversos , Implantación de Prótesis de Válvulas Cardíacas/métodos , Hemodinámica , Humanos , Masculino , Tempo Operativo , Complicaciones Posoperatorias/diagnóstico , Complicaciones Posoperatorias/fisiopatología , Complicaciones Posoperatorias/prevención & control , Estudios Prospectivos , Reproducibilidad de los Resultados , Índice de Severidad de la Enfermedad , Siberia , Técnicas de Sutura , Resultado del TratamientoRESUMEN
442 patients underwent the mitral valve replacement (MVR) with KemCor and PeriCor stented bioprostheses. The study results justified the preference of the "totally biological" PeriCor valve in patients with active infectious endocarditis. The longest follow-up period was 11 years, the mean follow-up was 51±34 months. The risk of the structural valve disfunction was shown to be inversely proportional to the age (p=0.03). 38% of the operated women younger the 45, developed the structural valve disfunction in 79±27 months after surgery. Thus, MVR with stented bioprostheses proved to be clinically efficient early after the operation. Predictability of the results of KemCor and PeriCor valve implantation allows the theoretically substantiated approach to the rehabilitation, especially, considering the adverse event rate in different patient groups at certain follow-up periods.
Asunto(s)
Bioprótesis , Enfermedades de las Válvulas Cardíacas , Implantación de Prótesis de Válvulas Cardíacas , Prótesis Valvulares Cardíacas , Válvula Mitral/cirugía , Complicaciones Posoperatorias , Adulto , Factores de Edad , Bioprótesis/efectos adversos , Bioprótesis/normas , Femenino , Enfermedades de las Válvulas Cardíacas/clasificación , Enfermedades de las Válvulas Cardíacas/mortalidad , Enfermedades de las Válvulas Cardíacas/cirugía , Prótesis Valvulares Cardíacas/efectos adversos , Prótesis Valvulares Cardíacas/normas , Implantación de Prótesis de Válvulas Cardíacas/efectos adversos , Implantación de Prótesis de Válvulas Cardíacas/métodos , Humanos , Masculino , Persona de Mediana Edad , Evaluación de Resultado en la Atención de Salud , Complicaciones Posoperatorias/clasificación , Complicaciones Posoperatorias/etiología , Complicaciones Posoperatorias/mortalidad , Factores de Riesgo , Análisis de Supervivencia , Resultado del TratamientoRESUMEN
A case report of a patient with a triple cardiac valve replacement complicated by severe postoperative intravascular hemolysis is presented. The patient had neither prosthetic valvular dysfunction nor paravalvular leak and had an excellent hemodynamic response to the operation. Replacement of the aortic and mitral prostheses with stented porcine prosthesis alleviated the problem.
Asunto(s)
Trastornos de la Coagulación Sanguínea/etiología , Prótesis Valvulares Cardíacas/efectos adversos , Trastornos de la Coagulación Sanguínea/sangre , Femenino , Estudios de Seguimiento , Hemoglobinas/metabolismo , Humanos , Persona de Mediana Edad , Estenosis de la Válvula Mitral/cirugía , Diseño de Prótesis , Falla de Prótesis , Índice de Severidad de la EnfermedadAsunto(s)
Queratitis Dendrítica/inmunología , Neutrófilos/inmunología , Linfocitos T/inmunología , Humanos , Inmunidad Celular , Interferón Tipo I/uso terapéutico , Queratitis Dendrítica/terapia , Poli A-U/uso terapéutico , Simplexvirus/inmunología , Factores de Tiempo , Vacunas Virales/uso terapéuticoRESUMEN
Glycosaminoglycan excretion with the urine was determined in 108 children born to mothers suffering from diabetes mellitus. In children with potential and latent diabetes, glycosaminoglycan excretion was increased as compared to children without diabetes mellitus aggravated heredity. The frequency of detection of increased glycosaminoglycan excretion in children did not depend on the length of the disease and its severity in mothers. Glycosaminoglycan excretion with the urine in potential diabetes of children may be regarded as a criterion of the risk of development of microcirculation disturbances of diabetic nature.
